Cequent Pharmaceuticals has appointed Michael Taylor to its board of directors.
Taylor is president and CEO of Ensemble Discovery, a biotechnology firm developing drugs and assays. Previously, he was senior vice president for Pfizer’s global research and development division.
He holds a PhD in medicinal chemistry from the State University of New York at Buffalo.